Latent Hit Identification in Primary Screening Data with Compound Set Enrichment
Thibault Varin, PostDoctoral Fellow, Novartis, Speaking at Medchem Europe 2011.
Date Posted: Thursday, December 01, 2011
Norvartis Splits Drug Business into Pharma, Oncology Divisons Novartis Pharmaceuticals and Novartis Oncology will form the Innovative Medicines Division at Novartis. Thursday, May 19, 2016Novartis Launches 'Novartis Access' Novartis portfolio to be offered to governments and non-governmental organizations in low- and low-middle-income countries for USD 1 per treatment, per month. Friday, September 25, 2015Novartis, Amgen Partner The companies plan to co-develop and co-commercialize a BACE inhibitor program in Alzheimer's Disease (AD); Novartis' oral therapy CNP520 will be the lead molecule. Friday, September 04, 2015